Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Health Economics and Management
Metadata
Title
Belgium’s mixed private/public health care system and its impact on the cost of end-stage renal disease
Authors
Wim Van Biesen
Norbert Lameire
Patrick Peeters
Raymond Vanholder
Publication date
01-09-2007
Publisher
Springer US
Published in
International Journal of Health Economics and Management / Issue 2-3/2007
Print ISSN: 2199-9023
Electronic ISSN: 2199-9031
DOI
https://doi.org/10.1007/s10754-007-9013-z

Other articles of this Issue 2-3/2007

International Journal of Health Economics and Management 2-3/2007 Go to the issue

OriginalPaper

The organization and financing of end-stage renal disease treatment in Japan

OriginalPaper

The organization and funding of the treatment of end-stage renal disease in Australia

OriginalPaper

International Study of Health Care Organization and Financing for end-stage renal disease in France

OriginalPaper

International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality

EditorialNotes

End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF)

OriginalPaper

The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care